Phibro Animal Health Corporation (PAHC) is a Healthcare stock trading at $31.86 (as of 2026-06-18), with a market capitalization of $1.26B and a trailing P/E of 13.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Phibro Animal Health Corporation develops, manufactures, and supplies animal health and mineral nutrition products for livestock, with a focus on the United States. It operates through Animal Health, Mineral Nutrition, and Performance Products, serving markets such as poultry, swine, beef and dairy cattle, and aquaculture with items including antibacterials, anticoccidials, anthelmintics, anti-bloat products, specialty nutrition products, and vaccines.